eMedicine Specialties > Sports Medicine > Introductory Topics in Sports Medicine
Myofascial Pain in Athletes: Multimedia
Updated: Feb 8, 2008
Multimedia
 | Media file 1:
Myofascial pain in athletes. Schematic of a
trigger point complex of a muscle in longitudinal
section. A: The central trigger point (CTrP) in the endplate zone contains numerous electrically active loci and numerous contraction knots. A taut band of muscle fibers extends from the trigger point to the attachment at each end of the involved fibers. The sustained tension that the taut band exerts on the attachment tissues can induce a localized enthesopathy that is identified as an attachment trigger point (ATrP). B: Enlarged view of part of the CTrP shows the distribution of 5 contraction knots. The vertical lines in each muscle fiber identify the relative spacing of its striations. The space between 2 striations corresponds to the length of one sarcomere. The sarcomeres within one of these enlarged segments (ie, contraction knot) of a muscle fiber are markedly shorter and wider than the sarcomeres in the neighboring normal muscle fibers, which are free of contraction knots. |
 | Media file 2:
Myofascial pain in athletes. Cross-sectional
drawing shows flat palpation of a taut band and its trigger
point. Left: Skin pushed to one side to begin palpation (A). The fingertip slides across muscle fibers to feel the cord-line texture of the taut band rolling beneath it (B). The skin is pushed to other side at completion of movement. This same movement performed vigorously is snapping palpation (C). Right: Muscle fibers surrounded by the thumb and fingers in a pincer grip (A). The hardness of the taut band is felt clearly as it is rolled between the digits (B). The palpable edge of the taut band is sharply defined as it escapes from between the fingertips, often with a local twitch response (C). |
 | Media file 3:
Myofascial pain in athletes. Longitudinal
schematic drawing of taut bands, myofascial trigger points, and
a local twitch response. A: Palpation of a taut band (straight lines) among normally slack, relaxed muscle fibers (wavy lines). B: Rolling the band quickly under the fingertip (snapping palpation) at the trigger point often produces a local twitch response that usually is seen most clearly as skin movement between the trigger point and the attachment of the muscle fibers. |
 | Media file 4: Myofascial pain in athletes. Sequence of steps to use when stretching and spraying any muscle for myofascial trigger points. |
 | Media file 5: Myofascial pain in athletes. Schematic drawing showing how the jet stream of Vapo coolant is applied. |
 | Media file 6: Myofascial pain in athletes. Cross-sectional schematic drawing shows flat palpation to localize and hold the trigger point for injection. A and B show use of alternate pressure between 2 fingers to confirm the location of the palpable module of the trigger point. C shows positioning the trigger point half way between the fingertips to keep it from sliding to one side during the injection. |
 | Media file 7: Myofascial pain in athletes. Schematic top view of 2 approaches to the flat injection of a trigger point area in a palpable taut band. Injection away from the fingers (A) and injection toward the fingers (B). |
 | Media file 8: Myofascial pain in athletes. C. Z. Hong's technique. Finger pressure beside the needle is used to indent the skin, subcutaneous, and fat tissues so that the needle can reach the trigger point in a muscle that would be inaccessible otherwise. |
 | Media file 9: Myofascial pain in athletes. Diagrammatic representation of pre-injection sites (open circles) and injection sites (solid circles) of local anesthetic to the trigger point. The enclosed stippled area represents the taut band. This diagram distinguishes the central trigger point within the large broken circle from the attachment trigger points located at the myotendinous junction and at the attachment of the tendon to the bone. Each of these 3 trigger point regions can be identified by their individual spot tenderness and anatomical locations. No rationale is apparent for injecting the part of the taut band that lies between the central trigger point and the attachment trigger point (solid circles numbers 7-10). |
 | Media file 10: Myofascial pain in athletes. Mechanism of botulinum toxin type A. |
 | Media file 11: Myofascial pain in athletes. Binding of neuromuscular transmission with botulinum toxin type A, which binds the motor nerve terminal. |
 | Media file 12: Myofascial pain in athletes. After botulinum toxin type A is internalized, the light chain of the toxin molecule is released into the cytoplasm of the nerve terminal. |
 | Media file 13: Myofascial pain in athletes. Botulinum toxin type A blocks acetylcholine by cleaving a cytoplasmic protein on the cell membrane. |
 | Media file 14: Myofascial pain in athletes. After the botulinum toxin type A exerts its clinical toxic effect, a nerve sprout eventually establishes a new neuromuscular junction, and muscle activity gradually returns. However, new research findings suggest that this new nerve sprout retracts and the original junction returns to functionality. |
 | Media file 15: Myofascial pain in athletes. After the clinical toxic effect of botulinum toxin type A occurs, axon sprouting and muscle fiber reinnervation terminate the clinical effect of the toxin, which results in the reestablishment of neuromuscular transmission. |
More on Myofascial Pain in Athletes |
| Overview: Myofascial Pain in Athletes |
| Differential Diagnoses & Workup: Myofascial Pain in Athletes |
| Treatment & Medication: Myofascial Pain in Athletes |
| Follow-up: Myofascial Pain in Athletes |
 Multimedia: Myofascial Pain in Athletes |
| References |
| « Previous Page |
References
Acquadro MA, Borodic GE. Treatment of myofascial pain with botulinum A toxin. Anesthesiology. Mar 1994;80(3):705-6. [Medline].
Charness ME, Parry GJ, Markison RE, et al. Entrapment neuropathies in musicians. Neurology. 1985;35(suppl 1):74.
Cheshire WP, Abashian SW, Mann JD. Botulinum toxin in the treatment of myofascial pain syndrome. Pain. Oct 1994;59(1):65-9. [Medline].
Coffield JA, Considine RV, Simpson LL. The site and mechanism of action of botulinum neurotoxin. In: Jankovic J, Hallet M, eds. Therapy with Botulinum Toxin. New York, NY: Marcel Dekker Inc; 1994:3-13.
Fisher AA. Diagnosis and management of chronic pain in physical medicine and rehabilitation. In: Ruskin AP, ed. Current Therapy in Physiatry. Philadelphia, Pa: WB Saunders Co; 1984:123-154.
Fredericson M, Weir A. Practical management of iliotibial band friction syndrome in runners. Clin J Sport Med. May 2006;3:261-8.
Fredericson M, Weir A. Practical management of iliotibial band friction syndrome in runners. Clin J Sport Med. May 2006;16(3):261-8.
Gregory PL, Biswas AC, Batt ME. Musculoskeletal problems of the chest wall in athletes. Sports Med. 2002;4:235-50.
Gregory PL, Biswas AC, Batt ME. Musculoskeletal problems of the chest wall in athletes. Sports Med. 2002;32(4):235-50.
Hatheway CL, Dang C. Immunogenicity of the neurotoxins of Clostridium botulinum. In: Jankovic J, Hallet M, eds. Therapy with Botulinum Toxin. New York, NY: Marcel Dekker; 1994:93-107.
Hong CZ. Treatment of myofascial pain syndrome. Curr Pain Headache Rep. Oct/2006;5:345-9.
Hong CZ. Treatment of myofascial pain syndrome. Curr Pain Headache Rep. Oct 2006;10(5):345-9.
Hubbard DR, Berkoff GM. Myofascial trigger points show spontaneous needle EMG activity. Spine. Oct 1 1993;18(13):1803-7. [Medline].
Lambert CM. Hand and upper limb problems of instrumental musicians. Br J Rheumatol. Apr 1992;31(4):265-71. [Medline].
Lederman RJ. Nerve entrapment syndromes in instrumental musicians. Med Probl Perform Art. 1986;1:45-8.
Maffulli N, Maffulli F. Transient entrapment neuropathy of the posterior interosseous nerve in violin players. J Neurol Neurosurg Psychiatry. Jan 1991;54(1):65-7. [Medline].
Reiter RC, Gambone JC. Nongynecologic somatic pathology in women with chronic pelvic pain and negative laparoscopy. J Reprod Med. Apr 1991;36(4):253-9. [Medline].
Rosen NB. Myofascial pain: the great mimicker and potentiator of other diseases in the performing artist. Md Med J. Mar 1993;42(3):261-6. [Medline].
Schneider MJ. Tender points/fibromyalgia vs. trigger points/myofascial pain syndrome: a need for clarity in terminology and differential diagnosis. J Manipulative Physiol Ther. Jul-Aug 1995;18(6):398-406. [Medline].
Scott AB. Forward. In: Jankovic J, Hallet M, eds. Therapy with Botulinum Toxin. New York, NY: Marcel Dekker Inc; 1994:vii-ix.
Simons AG. Muscular pain syndromes. In: Fricton JR, Awad FA, eds. Advances in Pain Research and Therapy. Myofascial Pain and Fibromyalgia. Vol 17. New York, NY: Raven Press; 1990:18.
Simons DG, Mense S. [Diagnosis and therapy of myofascial trigger points]. Schmerz. Dec 2003;17(6):419-24.
Thompson JM. The diagnosis and treatment of muscle pain syndromes. In: Braddom RL, ed. Physical Medicine and Rehabilitation. Philadelphia, Pa: WB Saunders Co; 1996.
Travell JG. Ethylchloride spray for painful muscle spasm. Arch Phys Med Rehabil. 1952;33:291-8.
Travell JG, Simons DG. Myofascial Pain and Dysfunction: The Trigger Point Manual. Baltimore, Md: Lippincott Williams & Wilkins; 1983.
Travell JG, Simons DG. Myofascial Pain and Dysfunction: The Trigger Point Manual. Upper half of Body. Vol 1. 2nd ed. Baltimore, Md: Lippincott Williams & Wilkins; 1999.
Wainapel SF, Cole IL. The not so magic flute: two cases of distal ullnar nerve entrapment. Med Probl Perform Art. 1988;3:63-5.
Walsh NE, Dimitru D, Schoenfeld LS, Ramamurthy S. Treatment of the patient with chronic pain. In: DeLisa JA, ed. Rehabilitation Medicine: Principles and Practice. 3rd ed. Philadelphia, Pa: Lippincott-Raven; 1998.
Further Reading
Keywords
myofascial pain syndromes, trigger points, MPS, myofascial trigger points, TrPs, MTrPs
